Cargando…

Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening

[Image: see text] Inhibition of the major cyclic adenosine monophosphate-metabolizing enzyme PDE4 has shown potential for the discovery of drugs for cancer, inflammation, and neurodegenerative disorders such as Alzheimer’s disease. As a springboard to explore new anti-cancer and anti-Alzheimer’s che...

Descripción completa

Detalles Bibliográficos
Autores principales: Quimque, Mark Tristan, Notarte, Kin Israel, Letada, Arianne, Fernandez, Rey Arturo, Pilapil, Delfin Yñigo, Pueblos, Kirstin Rhys, Agbay, Jay Carl, Dahse, Hans-Martin, Wenzel-Storjohann, Arlette, Tasdemir, Deniz, Khan, Abbas, Wei, Dong-Qing, Gose Macabeo, Allan Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015132/
https://www.ncbi.nlm.nih.gov/pubmed/33817501
http://dx.doi.org/10.1021/acsomega.1c00137
_version_ 1783673624573509632
author Quimque, Mark Tristan
Notarte, Kin Israel
Letada, Arianne
Fernandez, Rey Arturo
Pilapil, Delfin Yñigo
Pueblos, Kirstin Rhys
Agbay, Jay Carl
Dahse, Hans-Martin
Wenzel-Storjohann, Arlette
Tasdemir, Deniz
Khan, Abbas
Wei, Dong-Qing
Gose Macabeo, Allan Patrick
author_facet Quimque, Mark Tristan
Notarte, Kin Israel
Letada, Arianne
Fernandez, Rey Arturo
Pilapil, Delfin Yñigo
Pueblos, Kirstin Rhys
Agbay, Jay Carl
Dahse, Hans-Martin
Wenzel-Storjohann, Arlette
Tasdemir, Deniz
Khan, Abbas
Wei, Dong-Qing
Gose Macabeo, Allan Patrick
author_sort Quimque, Mark Tristan
collection PubMed
description [Image: see text] Inhibition of the major cyclic adenosine monophosphate-metabolizing enzyme PDE4 has shown potential for the discovery of drugs for cancer, inflammation, and neurodegenerative disorders such as Alzheimer’s disease. As a springboard to explore new anti-cancer and anti-Alzheimer’s chemical prototypes from rare Annonaceae species, the present study evaluated anti-PDE4B along with antiproliferative and anti-cholinesterase activities of the extracts of the Philippine endemic species Uvaria alba using in vitro assays and framed the resulting biological significance through computational binding and reactivity-based experiments. Thus, the PDE4 B2B-inhibiting dichloromethane sub-extract (UaD) of U. alba elicited antiproliferative activity against chronic myelogenous leukemia (K-562) and cytostatic effects against human cervical cancer (HeLa). The extract also profoundly inhibited acetylcholinesterase (AChE), an enzyme involved in the progression of neurodegenerative diseases. Chemical profiling analysis of the bioactive extract identified 18 putative secondary metabolites. Molecular docking and molecular dynamics simulations showed strong free energy binding mechanisms and dynamic stability at 50-ns simulations in the catalytic domains of PDE4 B2B, ubiquitin-specific peptidase 14, and Kelch-like ECH-associated protein 1 (KEAP-1 Kelch domain) for the benzylated dihydroflavone dichamanetin (16), and of an AChE and KEAP-1 BTB domain for 3-(3,4-dihydroxybenzyl)-3′,4′,6-trihydroxy-2,4-dimethoxychalcone (8) and grandifloracin (15), respectively. Density functional theory calculations to demonstrate Michael addition reaction of the most electrophilic metabolite and kinetically stable grandifloracin (15) with Cys151 of the KEAP-1 BTB domain illustrated favorable formation of a β-addition adduct. The top-ranked compounds also conferred favorable in silico pharmacokinetic properties.
format Online
Article
Text
id pubmed-8015132
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-80151322021-04-02 Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening Quimque, Mark Tristan Notarte, Kin Israel Letada, Arianne Fernandez, Rey Arturo Pilapil, Delfin Yñigo Pueblos, Kirstin Rhys Agbay, Jay Carl Dahse, Hans-Martin Wenzel-Storjohann, Arlette Tasdemir, Deniz Khan, Abbas Wei, Dong-Qing Gose Macabeo, Allan Patrick ACS Omega [Image: see text] Inhibition of the major cyclic adenosine monophosphate-metabolizing enzyme PDE4 has shown potential for the discovery of drugs for cancer, inflammation, and neurodegenerative disorders such as Alzheimer’s disease. As a springboard to explore new anti-cancer and anti-Alzheimer’s chemical prototypes from rare Annonaceae species, the present study evaluated anti-PDE4B along with antiproliferative and anti-cholinesterase activities of the extracts of the Philippine endemic species Uvaria alba using in vitro assays and framed the resulting biological significance through computational binding and reactivity-based experiments. Thus, the PDE4 B2B-inhibiting dichloromethane sub-extract (UaD) of U. alba elicited antiproliferative activity against chronic myelogenous leukemia (K-562) and cytostatic effects against human cervical cancer (HeLa). The extract also profoundly inhibited acetylcholinesterase (AChE), an enzyme involved in the progression of neurodegenerative diseases. Chemical profiling analysis of the bioactive extract identified 18 putative secondary metabolites. Molecular docking and molecular dynamics simulations showed strong free energy binding mechanisms and dynamic stability at 50-ns simulations in the catalytic domains of PDE4 B2B, ubiquitin-specific peptidase 14, and Kelch-like ECH-associated protein 1 (KEAP-1 Kelch domain) for the benzylated dihydroflavone dichamanetin (16), and of an AChE and KEAP-1 BTB domain for 3-(3,4-dihydroxybenzyl)-3′,4′,6-trihydroxy-2,4-dimethoxychalcone (8) and grandifloracin (15), respectively. Density functional theory calculations to demonstrate Michael addition reaction of the most electrophilic metabolite and kinetically stable grandifloracin (15) with Cys151 of the KEAP-1 BTB domain illustrated favorable formation of a β-addition adduct. The top-ranked compounds also conferred favorable in silico pharmacokinetic properties. American Chemical Society 2021-03-16 /pmc/articles/PMC8015132/ /pubmed/33817501 http://dx.doi.org/10.1021/acsomega.1c00137 Text en © 2021 The Authors. Published by American Chemical Society Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Quimque, Mark Tristan
Notarte, Kin Israel
Letada, Arianne
Fernandez, Rey Arturo
Pilapil, Delfin Yñigo
Pueblos, Kirstin Rhys
Agbay, Jay Carl
Dahse, Hans-Martin
Wenzel-Storjohann, Arlette
Tasdemir, Deniz
Khan, Abbas
Wei, Dong-Qing
Gose Macabeo, Allan Patrick
Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening
title Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening
title_full Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening
title_fullStr Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening
title_full_unstemmed Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening
title_short Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening
title_sort potential cancer- and alzheimer’s disease-targeting phosphodiesterase inhibitors from uvaria alba: insights from in vitro and consensus virtual screening
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015132/
https://www.ncbi.nlm.nih.gov/pubmed/33817501
http://dx.doi.org/10.1021/acsomega.1c00137
work_keys_str_mv AT quimquemarktristan potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT notartekinisrael potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT letadaarianne potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT fernandezreyarturo potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT pilapildelfinynigo potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT puebloskirstinrhys potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT agbayjaycarl potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT dahsehansmartin potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT wenzelstorjohannarlette potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT tasdemirdeniz potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT khanabbas potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT weidongqing potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening
AT gosemacabeoallanpatrick potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening